1065 related articles for article (PubMed ID: 22922757)
1. Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis.
Anastasiou D; Yu Y; Israelsen WJ; Jiang JK; Boxer MB; Hong BS; Tempel W; Dimov S; Shen M; Jha A; Yang H; Mattaini KR; Metallo CM; Fiske BP; Courtney KD; Malstrom S; Khan TM; Kung C; Skoumbourdis AP; Veith H; Southall N; Walsh MJ; Brimacombe KR; Leister W; Lunt SY; Johnson ZR; Yen KE; Kunii K; Davidson SM; Christofk HR; Austin CP; Inglese J; Harris MH; Asara JM; Stephanopoulos G; Salituro FG; Jin S; Dang L; Auld DS; Park HW; Cantley LC; Thomas CJ; Vander Heiden MG
Nat Chem Biol; 2012 Oct; 8(10):839-47. PubMed ID: 22922757
[TBL] [Abstract][Full Text] [Related]
2. 2-Oxo-N-aryl-1,2,3,4-tetrahydroquinoline-6-sulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinase.
Walsh MJ; Brimacombe KR; Veith H; Bougie JM; Daniel T; Leister W; Cantley LC; Israelsen WJ; Vander Heiden MG; Shen M; Auld DS; Thomas CJ; Boxer MB
Bioorg Med Chem Lett; 2011 Nov; 21(21):6322-7. PubMed ID: 21958545
[TBL] [Abstract][Full Text] [Related]
3. Serine is a natural ligand and allosteric activator of pyruvate kinase M2.
Chaneton B; Hillmann P; Zheng L; Martin ACL; Maddocks ODK; Chokkathukalam A; Coyle JE; Jankevics A; Holding FP; Vousden KH; Frezza C; O'Reilly M; Gottlieb E
Nature; 2012 Nov; 491(7424):458-462. PubMed ID: 23064226
[TBL] [Abstract][Full Text] [Related]
4. Small molecule activation of metabolic enzyme pyruvate kinase muscle isozyme 2, PKM2, circumvents photoreceptor apoptosis.
Wubben TJ; Pawar M; Weh E; Smith A; Sajjakulnukit P; Zhang L; Dai L; Hager H; Pai MP; Lyssiotis CA; Besirli CG
Sci Rep; 2020 Feb; 10(1):2990. PubMed ID: 32076076
[TBL] [Abstract][Full Text] [Related]
5. Succinyl-5-aminoimidazole-4-carboxamide-1-ribose 5'-Phosphate (SAICAR) Activates Pyruvate Kinase Isoform M2 (PKM2) in Its Dimeric Form.
Yan M; Chakravarthy S; Tokuda JM; Pollack L; Bowman GD; Lee YS
Biochemistry; 2016 Aug; 55(33):4731-6. PubMed ID: 27481063
[TBL] [Abstract][Full Text] [Related]
6. Native Mass Spectrometry Gives Insight into the Allosteric Binding Mechanism of M2 Pyruvate Kinase to Fructose-1,6-Bisphosphate.
Gavriilidou AFM; Holding FP; Mayer D; Coyle JE; Veprintsev DB; Zenobi R
Biochemistry; 2018 Mar; 57(11):1685-1689. PubMed ID: 29499117
[TBL] [Abstract][Full Text] [Related]
7. Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells.
Mazurek S
Int J Biochem Cell Biol; 2011 Jul; 43(7):969-80. PubMed ID: 20156581
[TBL] [Abstract][Full Text] [Related]
8. Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth.
Sun Q; Chen X; Ma J; Peng H; Wang F; Zha X; Wang Y; Jing Y; Yang H; Chen R; Chang L; Zhang Y; Goto J; Onda H; Chen T; Wang MR; Lu Y; You H; Kwiatkowski D; Zhang H
Proc Natl Acad Sci U S A; 2011 Mar; 108(10):4129-34. PubMed ID: 21325052
[TBL] [Abstract][Full Text] [Related]
9. Pyruvate kinase M2 is a phosphotyrosine-binding protein.
Christofk HR; Vander Heiden MG; Wu N; Asara JM; Cantley LC
Nature; 2008 Mar; 452(7184):181-6. PubMed ID: 18337815
[TBL] [Abstract][Full Text] [Related]
10. 1-(sulfonyl)-5-(arylsulfonyl)indoline as activators of the tumor cell specific M2 isoform of pyruvate kinase.
Yacovan A; Ozeri R; Kehat T; Mirilashvili S; Sherman D; Aizikovich A; Shitrit A; Ben-Zeev E; Schutz N; Bohana-Kashtan O; Konson A; Behar V; Becker OM
Bioorg Med Chem Lett; 2012 Oct; 22(20):6460-8. PubMed ID: 22963766
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of thieno[3,2-b]pyrrole[3,2-d]pyridazinones as activators of the tumor cell specific M2 isoform of pyruvate kinase.
Jiang JK; Boxer MB; Vander Heiden MG; Shen M; Skoumbourdis AP; Southall N; Veith H; Leister W; Austin CP; Park HW; Inglese J; Cantley LC; Auld DS; Thomas CJ
Bioorg Med Chem Lett; 2010 Jun; 20(11):3387-93. PubMed ID: 20451379
[TBL] [Abstract][Full Text] [Related]
12. Glucose Catabolism in Liver Tumors Induced by c-MYC Can Be Sustained by Various PKM1/PKM2 Ratios and Pyruvate Kinase Activities.
Méndez-Lucas A; Li X; Hu J; Che L; Song X; Jia J; Wang J; Xie C; Driscoll PC; Tschaharganeh DF; Calvisi DF; Yuneva M; Chen X
Cancer Res; 2017 Aug; 77(16):4355-4364. PubMed ID: 28630053
[TBL] [Abstract][Full Text] [Related]
13. Reciprocal regulation of protein kinase and pyruvate kinase activities of pyruvate kinase M2 by growth signals.
Gao X; Wang H; Yang JJ; Chen J; Jie J; Li L; Zhang Y; Liu ZR
J Biol Chem; 2013 May; 288(22):15971-9. PubMed ID: 23576436
[TBL] [Abstract][Full Text] [Related]
14. Structure-Guided Approach to Discover Tuberosin as a Potent Activator of Pyruvate Kinase M2, Targeting Cancer Therapy.
Adnan M; Shamsi A; Elasbali AM; Siddiqui AJ; Patel M; Alshammari N; Alharethi SH; Alhassan HH; Bardakci F; Hassan MI
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361954
[TBL] [Abstract][Full Text] [Related]
15. Insulin enhances metabolic capacities of cancer cells by dual regulation of glycolytic enzyme pyruvate kinase M2.
Iqbal MA; Siddiqui FA; Gupta V; Chattopadhyay S; Gopinath P; Kumar B; Manvati S; Chaman N; Bamezai RN
Mol Cancer; 2013 Jul; 12():72. PubMed ID: 23837608
[TBL] [Abstract][Full Text] [Related]
16. Isoform switch of pyruvate kinase M1 indeed occurs but not to pyruvate kinase M2 in human tumorigenesis.
Zhan C; Yan L; Wang L; Ma J; Jiang W; Zhang Y; Shi Y; Wang Q
PLoS One; 2015; 10(3):e0118663. PubMed ID: 25738776
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for allosteric regulation of pyruvate kinase M2 by phosphorylation and acetylation.
Nandi S; Razzaghi M; Srivastava D; Dey M
J Biol Chem; 2020 Dec; 295(51):17425-17440. PubMed ID: 33453989
[TBL] [Abstract][Full Text] [Related]
18. Pyruvate kinase: Function, regulation and role in cancer.
Israelsen WJ; Vander Heiden MG
Semin Cell Dev Biol; 2015 Jul; 43():43-51. PubMed ID: 26277545
[TBL] [Abstract][Full Text] [Related]
19. No evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesis.
Bluemlein K; Grüning NM; Feichtinger RG; Lehrach H; Kofler B; Ralser M
Oncotarget; 2011 May; 2(5):393-400. PubMed ID: 21789790
[TBL] [Abstract][Full Text] [Related]
20. Evidence for an alternative glycolytic pathway in rapidly proliferating cells.
Vander Heiden MG; Locasale JW; Swanson KD; Sharfi H; Heffron GJ; Amador-Noguez D; Christofk HR; Wagner G; Rabinowitz JD; Asara JM; Cantley LC
Science; 2010 Sep; 329(5998):1492-9. PubMed ID: 20847263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
